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Background: Gal-geun-dang-gwi-tang (GGDGT), an herbal medicine, is used to treat hypertension, stroke, and
other inflammatory disorders in the clinical setting. Recently, GGDGT was recognized by the Korea Institute of
Oriental Medicine. This study aimed to evaluate the effects of GGDGT in a diabetic atherosclerosis model using
apolipoprotein E knockout (ApoE−/−) mice fed a Western diet.
Methods: The mice were divided into four groups: control group, C57BL6J mice receiving a regular diet (RD);
ApoE−/− group, ApoE−/− mice receiving a Western diet (WD); rosiglitazone group, ApoE−/− mice receiving
rosiglitazone (WD + 10 mg · kg−1 · day−1); GGDGT group, ApoE−/− mice receiving GGDGT (WD + 200 mg · kg−1 · day−1).
Results: Treatment with GGDGT significantly improved glucose tolerance and plasma lipid levels. In addition, GGDGT
ameliorated acetylcholine-induced vascular relaxation of the aortic rings. Immunohistochemical staining showed that
GGDGT suppressed intercellular adhesion molecule (ICAM)-1 expression; however, expression of endothelial nitric
oxide synthase (eNOS) and insulin receptor substrate (IRS)-1 were restored in the thoracic aorta and skeletal muscle,
respectively.
Conclusions: These findings suggest that GGDGT attenuates endothelial dysfunction via improvement of the nitric
oxide (NO)-cyclic guanosine monophosphate (cGMP) signalling pathway and improves insulin sensitivity in diabetic
atherosclerosis.
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Migration of circulating monocytes into the vessel wall is
an important step in the development of diabetic athero-
sclerosis, a chronic inflammatory condition. Hypercholes-
terolemia produces numerous functional and structural
alterations in the vascular walls and leads to the develop-
ment of atherosclerosis [1]. Insulin resistance, an impor-
tant feature of metabolic diseases, serves as a common
pathophysiological basis shared by cardiovascular dis-
eases such as diabetes, hyperlipidemia, hypertension, and* Correspondence: dgkang@wku.ac.kr; host@wku.ac.kr
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unless otherwise stated.hyperglycemia [2,3]. Production of local reactive oxygen
species can increase low-density lipoprotein (LDL) oxi-
dation, local inflammation, vascular adventitial fibro-
blast proliferation, and extracellular matrix synthesis.
Local reactive oxygen species can also directly activate
nuclear factor kappa B (NF-κB) and stimulate the ex-
pression of NF-κB-dependent genes, including the genes
of pro-inflammatory factors related to atherosclerosis,
such as intercellular adhesion molecule (ICAM)-1. In-
creased expression of pro-inflammatory genes advances
the atherosclerotic process and vascular remodelling [4,5].
A high-cholesterol Western diet causes atherosclerotic
plaque formation, vascular inflammation, and lipid me-
tabolism disorders and leads to hyperlipidemia and insu-
lin resistance, which are characterized by high levels of
serum triglycerides and total cholesterol [6-8]. Higher
serum LDL results in increased risk of atherosclerosis. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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protein (HDL) protects against atherosclerosis [9]. Many
epidemiological, clinical, and experimental studies have
indicated that reducing high serum LDL is an effective
way to prevent atherosclerosis and cardiovascular dis-
eases [10]. Moreover, vascular tone is an important fac-
tor in the regulation of arterial blood pressure. Changes
in vascular smooth muscle tone and the internal diam-
eter of vessels can profoundly alter tissue perfusion and
impair the ability of arteries to respond to vasodilators
and vasoconstrictors. The endothelium-dependent vaso-
relaxation that is induced by acetylcholine (ACh) is me-
diated by nitric oxide (NO), which acts through soluble
guanylyl cyclase and cyclic guanosine monophosphate
(GMP). Thus, this phenotypic change appears to result
from a decline in NO bioavailability due to impaired
NO biosynthesis and inactivation of NO by superoxide,
which leads to hypertension. A recent study showed
that ACh-induced relaxation was decreased in apolipo-
protein E knockout (ApoE−/−) mouse aortas, but the
dysfunction was strictly correlated with the develop-
ment and size of atherosclerotic plaques. This indicates
that the endothelial defect is not determined by hyper-
cholesterolemia alone, but is predominantly associated
with plaque formation [11,12]. These impaired vascular
responses have been found in hypercholesterolemic ani-
mals [13,14] and humans [15]. Impaired relaxation of
the aorta in response to ACh in obese rats is a conse-
quence of endothelial dysfunction [16].
In traditional Oriental medicine, various herbs or her-
bal prescriptions have long been used to treat vascular
disorders such as stroke or atherosclerosis [17]. Gal-
geun-dang-gwi-tang (GGDGT), a Korean herbal medi-
cine, has traditionally been prescribed for the treatment
of diabetes. GGDGT has been in clinical use for many
years, and the Korea Institute of Oriental Medicine in-
cluded GGDGT in a compilation published in 2004 [18].
However, the mechanism of GGDGT has yet to be clari-
fied. Therefore, we used ApoE−/− mice as an animal
model of diabetic atherosclerosis [19-21] and rosiglita-
zone as a positive control to investigate the beneficial ef-




The 17 herbal ingredients of GGDGT were purchased
from the Herbal Medicine Cooperative Association
(Iksan, Korea). A voucher specimen (No. HBA091) has
been deposited in the Herbarium of the Professional
Graduate School of Oriental Medicine, Wonkwang Uni-
versity (Korea). The ingredients of GGDGT include Puer-
aria lobata Ohwi, Glycyrrhiza uralensis Fischer, Angelica
gigas Nakai, Liriope platyphylla Wang et Tang, Paeoniajaponica (Makino) Miyabe & Takeda, Cornus officinalis,
Chaenomeles sinensis Koehne, Rehmannia glutinosa
Liboschitz var. purpurea Makino, Nelumbo nucifera
Gaertner, Prunus mume Sieb et Zucc, Schisandra chinen-
sis (Turcz.) Baill, Phyllostachys nigra Munro var. henosis
Stapf, Anemarrhena asphodeloides Bunge, Cnidium offi-
cinale Makino, Asparagus cochinchinensis (Lour.) Merr,
Trichosanthes kirilowii Maximowicz, and Cyperus rotun-
dus L. The herbal mixture was boiled and then dried to
form granules.
Experimental animals
The animal procedures were in strict accordance with
the 1985 (revised 1996) guidelines for the care and use
of laboratory animals of the U.S. National Institutes of
Health and were approved by the Institutional Animal
Care and Utilization Committee for Medical Science
of Wonkwang University. Six-week-old male ApoE−/−
C57BL6J mice (n = 36) and normal C57BL6J mice (n = 12)
were obtained from Central Laboratory Animal (Seoul,
Korea). Mice were started on a Western diet (WD) con-
taining 0.15% cholesterol and providing 42% calories from
fat (TD 88137; Harlan Teklad, Madison, WI) at 6 weeks of
age, and maintained on this diet for an additional 12
weeks. Throughout the experiments, all animals had unre-
stricted access to water. After two weeks of acclimatiza-
tion, animals were randomly divided into four groups
(n = 12 per group). In the control group, C57BL6J mice re-
ceived a regular diet (RD). The peroxisome proliferator-
activated receptor-γ (PPAR-γ) agonist, rosiglitazone, was
chosen as a positive control. Rosiglitazone is an anti-
diabetic drug for the treatment of type 2 diabetes [22]. In
the rosiglitazone group, ApoE−/− mice received rosiglita-
zone (WD+ 10 mg · kg−1 · day−1). In the GGDGT group,
ApoE−/− mice received GGDGT (WD+ 200 mg · kg−1 ·
day−1). At the end of the study, the mice were fasted over-
night and their organs were collected.
Measurement of blood pressure
Systolic blood pressure (SBP) was determined by a tail-
cuff plethysmography method and recorded with an
automatic sphygmotonograph (Muromachi Kikai, Tokyo,
Japan). At least eight determinations were made in every
session, and the mean of the lowest five values within
5 mm Hg was taken as the systolic blood pressure level.
Oral glucose tolerance test
At the end of week 2 of the experimental period, the mice
were fasted overnight before administration of glucose
(1.5 g/kg). Blood samples were collected from the tail at
various time points (0–120 min) after glucose loading,
and blood glucose levels were measured with a Onetouch
Ultra blood glucose meter and test strip (LifeScan, Inc.,
Milpitas, CA).
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The blood glucose concentration was measured at 1, 4,
8, and 11 weeks of GGDGT supplementation. The blood
glucose concentration was measured with whole blood
obtained from the tail veins after withholding food for
6 h using a Onetouch Ultra blood glucose meter and test
strip (LifeScan, Inc.). Plasma levels of total cholesterol
(T-Cho) and triglycerides (TG) were enzymatically mea-
sured using commercially available kits (Arkray Factory,
Inc., Kyoto, Japan). Plasma insulin levels were determined
by an ultrasensitive mouse insulin ELISA (enzyme-linked
immunosorbent assay) (ALPCO Diagnostics, Salem, NH),
and plasma leptin levels were measured using a mouse
leptin ELISA (Crystal Chem, Downers Grove, IL).
Recording of isometric vascular tone
Vascular tone was determined as previously described by
Kang et al. [23]. At the end of the experiment, the mice
were sacrificed by decapitation. The thoracic aorta was
rapidly and carefully dissected and placed in ice-cold
Krebs solution (118 mM NaCl, 4.7 mM KCl, 1.1 mM
MgSO4, 1.2 mM KH2PO4, 1.5 mM CaCl2, 25 mM
NaHCO3, and 10 mM glucose, pH 7.4). The aortas were
removed free of connective tissue and fat and cut into
rings with a width of approximately 3 mm. All dissecting
procedures were done with extreme care to protect the
endothelium from inadvertent damage. The aortic rings
were suspended by means of two L-shaped stainless steel
wires inserted into the lumen in a tissue bath containing
Krebs solution at 37°C. A gas mixture of 95% O2 and 5%
CO2 was continuously bubbled through the bath. The
baseline load placed on the aortic rings was 1.0 g. Changes
in isometric tension were recorded using a Grass model
FT 03 force displacement transducer (Grass Technologies,
Quincy, MA) connected to a model 7E polygraph recor-
ding system (Grass Technologies). The aortic rings were
washed every 10 min with Krebs solution until the tension
returned to the basal level. After being stabilized, the
aortic rings were contracted with phenylephrine (1 μM), a
selective α1-adrenergic receptor agonist, to obtain a ma-
ximal response, and then a concentration-dependent
response curve to ACh, a vasodilator that stimulates
endothelial release of NO, or sodium nitroprusside
(SNP), an exogenous NO donor, was determined in the
thoracic aorta.
Histological examination
Aortas isolated from all groups were fixed with 10%
(v/v) formalin and embedded in paraffin (50 mM potas-
sium paraffin). Then cross-sections (6 μm) of the aortic
arch in each group were stained with haematoxylin and
eosin (H&E) [24]. The Oil-red O stain was used to identify
lipid accumulation in the plaque. Assessments were made
using en face preparations of whole descending aortas aspreviously described [25]. Briefly, blood was removed
from dissected descending thoracic aortas by perfusion
with phosphate-buffered saline (PBS). Then the aortas
were opened longitudinally with extremely fine micro-
scissors (George Tiemann & Co, Hauppauge, NY) and
turned inside-out to expose the endothelium. The dis-
sected aortas were washed in distilled water and then in
100% propylene glycol and stained with 1% Oil-red O
(Sigma Chemical Co., St. Louis, MO) for 25 min at room
temperature. Aortas were washed again in 60% propylene
glycol and distilled water, mounted on glass slides, and
coverslipped using an aqueous medium (Aquatex; Merck,
Darmstadt, Germany). Forty fields in three individual
sections were randomly selected from the H&E and
Oil-red O stained areas. Representative sections were
photographed, and quantification of immunohistological
staining was conducted by Axiovision 4 imaging/archiving
software (Carl Zeiss, Jena, Germany).
Immunohistochemistry
Sections were stained before they were incubated with
5% normal goat serum for 10 min at room temperature
to reduce nonspecific background staining. ICAM-1
(Zymed Laboratories Inc., San Francisco, CA) and endo-
thelial nitric oxide synthase (eNOS) antibody (Oncogene,
Cambridge, MA) were applied as a 1:500 dilution and
incubated in humidified chambers overnight at 4°C. All
slides were then sequentially incubated with biotinylated
secondary antibody and horseradish peroxidase–conju-
gated streptavidin, both for 10 min at room temperature.
Peroxidase activity was visualized by the 3-amino-9-
ethylcarbazole (AEC) substrate-chromogen system
(Zymed), which resulted in brownish-red staining, as
previously described by Matsuda et al. [26]. Representa-
tive sections were photographed, and quantification of
immunohistological staining was conducted by Axiovision
4 imaging/archiving software (Carl Zeiss).
Western blot analysis
Samples of thoracic aorta were homogenized in a buffer
consisting of 250 mM sucrose, 1 mM EDTA, 0.1 mM
phenylmethylsulfonyl fluoride (PMSF), and 20 mM po-
tassium phosphate buffer, at pH 7.6. Tissue homogenates
(40 μg of protein) were separated by 10% sodium do-
decyl sulfate (SDS)-polyacrylamide gel electrophoresis
and transferred to nitrocellulose paper. Blots were then
washed with H2O, blocked with 5% skimmed milk pow-
der in TBST (10 mM Tris–HCl [pH 7.6], 150 mM NaCl,
0.05% Tween-20) for 1 h, and incubated with the appro-
priate primary antibody at dilutions recommended by
the supplier. Then the membrane was washed, and pri-
mary antibodies were detected with goat anti-rabbit-IgG
conjugated to horseradish peroxidase, and the bands were
visualized with enhanced chemiluminescence (Amersham,
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determined by analysing the signals captured on the nitro-
cellulose membranes using the Chemi-doc image analyser
(Bio-Rad, Hercules, CA).
Statistical analysis
All the experiments were repeated at least three times.
The results were expressed as mean ± standard error of
the mean (SEM). All statistical analysis was performed
using one-way analysis of variance (ANOVA) followed
by the Student t-test using Sigma Plot (version 10.0).
Values of p < 0.05 were considered statistically significant.
Results and discussion
The present study provides the first evidence that
GGDGT significantly attenuates diabetic atherosclerotic
development through the inhibition of endothelial dys-
function and insulin resistance. GGDGT, based on its
effective combination of medicinal herbs, is included
among contemporary prescriptions and has been widely
used for many years in the clinical setting. The Korea
Institute of Oriental Medicine has published a compil-
ation of herbal prescriptions (‘Usugyeongheombangjip, anTable 1 Effects of GGDGT on body weight, water intake, food
ApoE−/− mice
0
Body weight (g) Control 22.33 ± 0.67
ApoE −/− 22.57 ± 0.65
Rosiglitazone 22.07 ± 0.59
GGDGT 21.45 ± 0.35
Water intake (g/day) Control 37.63 ± 2.19
ApoE −/− 38.98 ± 2.92
Rosiglitazone 38.74 ± 3.01
GGDGT 29.62 ± 2.11
Food intake (g/day) Control 19.87 ± 0.45
ApoE −/− 18.06 ± 0.31
Rosiglitazone 16.58 ± 0.35
GGDGT 17.60 ± 0.52
Glucose (mg/dl) Control 119.60 ± 1.6
ApoE −/− 123.80 ± 9.2
Rosiglitazone 127.33 ± 7.5
GGDGT 129.33 ± 4.3
Systolic blood pressure (mmHg) Control 102.06 ± 1.4
ApoE −/− 102.83 ± 1.9
Rosiglitazone 101.53 ± 1.6
GGDGT 111.25 ± 1.3
Body weight expressed the mean of absolute weight of mice. ApoE−/−, apolipopro
GGDGT, WD + 200 mg/day/kg GGDGT. Values are expressed as mean ± S.E. values (n
ApoE−/− mice.excellent collection of prescriptions used in the clinical
experience in Korea’) that have shown excellent effects
in the treatment of diabetic atherosclerosis in modern
diseases.Effects of GGDGT on metabolism and blood pressure
Hypertension is not always uniformly observed in obe-
sity induced by elevated-fat diets in animal models of
endothelial dysfunction [27,28]. However, we observed
an elevation in SBP in WD-fed ApoE−/− mice. We mea-
sured the mean SBP using a tail-cuff technique. As
shown in Table 1, WD-fed ApoE−/− mice showed sig-
nificantly increased body weight compared with RD-fed
control mice, while body weight was significantly de-
creased by treatment with GGDGT. Moreover, prior to
the start of the experiment (week 0), the mice were not
fed a Western diet. Initiation of feeding with a WD re-
sulted in increased SBP in the ApoE−/− mice. However,
in the ApoE−/− mice treated with GGDGT, the SBP did
not change between week 0 and week 11. Therefore, we
think that GGDGT suppressed the increase in blood
pressure observed in WD-fed ApoE−/− mice.intake, blood glucose, and blood pressure levels in
Weeks
4 8 11
24.08 ± 0.79 25.73 ± 0.79 27.42 ± 0.87
28.23 ± 0.70** 33.60 ± 1.01** 37.55 ± 0.90**
27.25 ± 0.97# 31.77 ± 1.22## 34.47 ± 1.35##
25.42 ± 0.56# 29.95 ± 0.95## 32.43 ± 1.16##
44.68 ± 2.15 39.38 ± 3.00 50.59 ± 0.67
31.31 ± 2.68 23.21 ± 1.97 30.53 ± 3.07
30.08 ± 0.72 25.05 ± 0.71 22.68 ± 1.28
23.18 ± 1.82 21.30 ± 1.53 24.45 ± 2.00
24.33 ± 0.93 20.85 ± 0.52 20.65 ± 0.55
18.37 ± 0.26 17.58 ± 0.49 15.98 ± 0.42
15.00 ± 0.22 14.02 ± 0.62 12.77 ± 0.79
16.24 ± 0.33 16.17 ± 0.20 14.11 ± 0.43
3 114.00 ± 5.30 102.00 ± 2.48 113.67 ± 3.48
8 104.00 ± 6.66 114.60 ± 6.87 138.25 ± 3.42**
4 95.25 ± 14.44 097.75 ± 2.75 113.75 ± 3.25##
7 98.67 ± 1.48 107.50 ± 3.27 118.20 ± 3.64##
7 103.16 ± 1.2 104.16 ± 1.33 109.00 ± 0.91
8 110.42 ± 1.56 117.32 ± 1.75 128.83 ± 1.62**
8 104.20 ± 0.93 104.95 ± 1.17 110.03 ± 0.76##
2 106.80 ± 1.02 106.90 ± 0.95 112.15 ± 0.82##
tein E knockout mouse; Rosiglitazone, WD + 10 mg/day/kg rosiglitazone;
= 12). **p < 0.01, vs. RD-fed control mice; #p < 0.05, ##p < 0.01 vs. WD-fed
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high cholesterol-induced elevation in SBP. In addition,
WD-fed ApoE−/− mice had significantly increased
plasma blood glucose and insulin levels (Table 2) com-
pared to RD-fed control mice. However, treatment with
GGDGT and rosiglitazone clearly lessened the increase
in blood glucose (p < 0.01) and insulin (p < 0.05) levels in
WD-fed ApoE−/− mice. WD-fed ApoE−/− mice showed
significantly increased body weight compared with RD-
fed control mice, while weight gain was significantly less
in mice treated with GGDGT. It should be noted that
during the 12 weeks of the WD regimen, cumulative food
and water intake among the four groups was not signifi-
cantly different (p > 0.05) (Table 1).
GGDGT and lipid metabolism
Hypercholesterolemia is a common risk factor for early
atherosclerosis. Prior to the appearance of atheroscler-
otic changes in the vascular wall, a high cholesterol level
induces vascular functional changes that may lead to
vascular remodelling and increases permeability of LDL-
cholesterol [29]. Elevated total and LDL-cholesterol le-
vels impair endothelial function, and LDL-cholesterol is
deposited in the blood vessel wall as part of atherosclero-
tic plaques [30,31]. However, increased HDL-cholesterol
could suppress the atherosclerotic process by facilitating
translocation of cholesterol from peripheral tissues like ar-
terial walls to the liver for catabolism [24,32]. In ApoE−/−
mice, which lack the means to metabolize lipids, a
fat-enriched diet can elevate the LDL-cholesterol level in
plasma [33,34]. Furthermore, ApoE−/− mice developed
atherosclerosis, hypertension, impaired fasting glucose,
impaired glucose tolerance, and modest dyslipidaemia. As
expected, plasma leptin concentrations were also in-
creased in mice that developed atherosclerosis [35]. In the
present study, plasma levels of total cholesterol were sig-
nificantly increased (p < 0.001) in WD-fed ApoE−/− mice;
however, in mice treated with GGDGT and rosiglitazone,
they were clearly decreased (p < 0.01). Triglyceride con-
centrations were increased in WD-fed ApoE−/− mice,
whereas they were decreased (p < 0.01) in mice receiving
rosiglitazone and GGDGT. In addition, leptin concen-
trations were markedly increased in WD-fed ApoE−/−Table 2 Effects of GGDGT on lipid profile, leptin, and insulin
Control ApoE
Total cholesterol (mg/dl) 81.67 ± 4.98 393.00 ±
Triglyceride (mg/dl) 53.67 ± 4.41 98.67 ±
Leptin (mg/dl) 636.17 ± 20.5 2636.38
Insulin (mg/dl) 2.28 ± 0.34 6.03 ±
Values are expressed as mean ± S.E. values (n = 12 mice per group). **p < 0.01, ***p
ApoE−/− mice.mice compared to RD-fed control mice, while significantly
decreased (p < 0.001) in mice receiving GGDGT (Table 2).
These findings, at least in part, indicate that GGDGT may
protect against the initiation and development of athero-
sclerosis by improving lipid metabolism.
GGDGT and vascular morphology
Endothelial dysfunction includes not only reduced va-
sodilation but also inflammation and atherosclerotic le-
sions [36,37]. Blocking inflammatory mediators could
decrease the size of atherosclerotic lesions. We hypothe-
sized that the vasorelaxant effect of GGDGT would pro-
duce anti-inflammatory and anti-atherosclerotic effects
in WD-fed ApoE−/− mice. Microscopic examination of
H&E stained thoracic aortic sections revealed roughened
endothelial layers in WD-fed ApoE−/− mice. The aortic
sections of WD-fed ApoE−/− mice also showed signifi-
cantly increased tunica intima thickness. Treatment with
GGDGT and rosiglitazone for 12 weeks maintained the
smooth and soft character of the intima endothelial la-
yers and decreased intima-media thickness in aortic sec-
tions. Moreover, WD-fed ApoE−/− mice were observed
to have larger atherosclerotic lesions, whereas athero-
sclerotic lesions were not observed in mice treated with
GGDGT and rosiglitazone (Figure 1A). In addition, oil-
red O staining of atherosclerotic plaques is visible as a
red colour. Figure 1B shows the proximal portion of the
descending thoracic aorta that has been turned inside-
out to expose the stained endothelium. The surface area
covered with atherosclerotic plaque was statistically
higher in the aortas of WD-fed ApoE−/− mice than in
RD-fed control mice, whereas aortas from mice treated
with GGDGT and rosiglitazone did not show significant
atherosclerotic lesions. Previous histological analysis has
demonstrated that rougher intimal endothelial layers in
aortic sections of WD-fed ApoE−/− mice were associa-
ted with a trend towards a thickened medial layer [38,39].
Thus, feeding ApoE−/− mice a fat-enriched WD could
induce thickening of the aortic intima-media that is
compatible with the processes of atherosclerosis and in-
timal derangement, and our experiments showed that
these morphological changes could be prevented by
GGDGT treatment.in ApoE−/− mice
−/− Rosiglitazone GGDGT
1.53*** 118.00 ± 9.02### 349.67 ± 7.54##
2.40** 49.67 ± 2.33## 37.67 ± 2.85##
± 41*** 1362.5 ± 99.8### 986.33 ± 78.95###
0.63** 2.66 ± 0.48## 3.24 ± 0.79#
< 0.001 vs. RD-fed control mice; ##p < 0.01, ###p < 0.001 vs. WD-fed
Figure 1 Representative images showing aortic histology in control, ApoE−/−, rosiglitazone-treated, and GGDGT-treated mice at
week 12. The upper panel (A) indicates haematoxylin and eosin (H&E) staining (×400) in cross-section, and the lower panel (B) indicates Oil-red
O staining (×100) (n = 6). The lipid accumulation (violet colour) is indicated by an arrow in the Oil-red O staining.
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relaxation
The endothelium can sense changes or abnormalities in
blood flow and pressure, and the vascular endothelium
exists between circulating blood and vascular smooth
muscle cells, while the vascular smooth muscle plays the
important role of modulating vascular tone [40]. Recent
studies showing improvements in insulin-regulated vas-
cular homeostasis through the restoration of vascular
constriction in various animal models suggest a relation
between insulin signalling and vascular dysfunction
[41-43]. Figure 2 shows the effect of GGDGT on vaso-
dilatory response to ACh or SNP in aortic strips with
endothelium from the WD-fed ApoE−/− mice. The rela-
tive relaxation induced by ACh was attenuated in thor-
acic aortas taken from the mice fed an atherogenic diet
compared with that of the control group (p < 0.05). ACh-
induced vascular relaxation in the aortas taken from
GGDGT treated WD-fed ApoE−/− mice was in some re-
spects similar to that of RD-fed control mice (Figure 2A).
However, vasodilation in response to low concentrations
of SNP, an exogenous NO donor, was not significantlyFigure 2 Effect of GGDGT on relaxation of the thoracic aorta in Weste
acetylcholine (Ach), and (B) aortic relaxation induced by sodium nitropruss
*p < 0.05, **p < 0.01 vs. regular diet-fed control mice; #p < 0.05, ##p < 0.01,decreased by treatment with GGDGT and rosiglitazone
for 12 weeks (Figure 2B). Furthermore, Figure 3 displays
representative pictures of eNOS expression in thoracic
aortic sections of WD-fed ApoE−/− mice using immuno-
histochemistry. The expression of eNOS was suppressed
in the aortas of WD-fed ApoE−/− mice compared with
RD-fed control mice. Treatment with GGDGTand rosigli-
tazone markedly restored expression levels of eNOS by
44% and 65%, respectively. These finding suggest that the
hypotensive effect of GGDGT is mediated by ACh and via
the endothelium-dependent NO-cGMP pathway. In fact,
endothelial dysfunction was initially identified as im-
paired vasodilation to specific stimuli such as ACh or
bradykinin, therefore, improvement of endothelial func-
tion is predicted to regulate lipid homeostasis [44]. Im-
pairment of ACh-induced relaxation of the aorta was
observed in obese, diabetic, fatty rats because of endo-
thelial dysfunction [45]. It has been well documented
that endothelium-dependent vascular relaxation is ab-
normal in both hypercholesterolemia and atheroscler-
osis because of NO’s role in maintaining vascular tone
[46,47]. Thus, our finding suggests that GGDGT playsrn diet (WD)-fed ApoE−/− mice. (A) Aortic relaxation induced by
ide (SNP). Data are mean ± S.E. values (n = 10 mice per group).
###p < 0.001 vs. WD-fed ApoE−/− mice.
Figure 3 Effect of GGDGT on eNOS expression in the aorta of Western diet (WD)-fed ApoE−/− mice. (A) Representative microscopic
photographs of aortas immunodetected for endothelial nitric oxide synthase (eNOS) (upper panels, magnification × 100; middle panels,
magnification × 400; lower panels, magnification × 100). (B) Quantification of eNOS expression. Aortas were obtained from regular diet (RD)-fed
control mice, WD-fed ApoE−/− mice, rosiglitazone-treated mice, and Gal-geun-dang-gwi-tang (GGDGT)-treated mice. Values are expressed as a
percentage of the density of the blot coloured dark brown (mean ± S.E.) (n = 6 mice per group). **p < 0.01 vs. RD-fed control mice; ##p < 0.01
vs. WD-fed ApoE−/− mice.
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constriction. Further studies are required to measure
plasma nitrate/nitrite levels and vascular relaxation by
SNP after Ach, which is the alleviation of endothelial dam-
age in vascular dysfunction seen with GGDGT treatment.
GGDGT and vascular inflammatory markers: ICAM-1
expression
Reduced vasodilation, inflammation, and atherosclerotic
lesions are associated with endothelial dysfunction [36,37].
Activation of the endothelium at sites of inflammation al-
lows numerous leukocytes to adhere to the vascular endo-
thelium, transmigrates the endothelium, and aggravates
endothelial dysfunction and tissue injury [48]. In leukocyte
infiltration, the sites of inflammation are regulated in part
by specific endothelial-leukocyte adhesion molecules,
including vascular cell adhesion molecule-1 (VCAM-1),
ICAM-1, and E-selectin [49]. In a previous study, weFigure 4 Effect of GGDGT on ICAM-1 immunoreactivity in the aorta o
staining of ICAM-1 in aortas from regular diet (RD)-fed control mice, WD-fe
ApoE−/− mice treated with Gal-geun-dang-gwi-tang (GGDGT) (upper pane
panels, magnification × 100). (B) Quantitative analysis of ICAM-1 immunore
selected aortas was calculated. Data are expressed as mean ± S.E. values (n
##p < 0.01 vs. WD-fed ApoE−/− mice.investigated the effect of Gal-geun-dang-gwi-tang in
suppressing the expression of cell adhesion molecules,
such as VCAM-1, ICAM-1, and E-selectin, in vascular
endothelial cells stimulated by high glucose. Pre-treatment
with Gal-geun-dang-gwi-tang significantly inhibited high
glucose-induced expression of VCAM-1, ICAM-1, and E-
selectin in a dose-dependent manner (Additional file 1:
Figure S1). Therefore, we chose this herbal prescription to
investigate diabetic vascular complications in a murine
model. We hypothesized that the vasorelaxant effect of
GGDGT would contribute anti-inflammatory and anti-
atherosclerotic effects in mice fed a fat-enriched WD.
In this study, analysis of immunohistochemical staining
showed that ICAM-1 was weakly expressed in the thor-
acic aortas of the RD-fed control mice, but was mark-
edly increased in WD-fed ApoE−/− mice. In contrast,
ICAM-1 expression was significantly decreased by treat-
ment with GGDGT (p < 0.05) (Figure 4). Expression levelsf Western diet (WD)-fed ApoE−/− mice. (A) Immunohistochemical
d ApoE−/− mice, ApoE−/− mice treated with rosiglitazone, and
ls, magnification × 100; middle panels, magnification × 400; lower
activity in the thoracic aorta. The average score for 5–10 randomly
= 6 mice per group). **p < 0.01 vs. RD-fed control mice; #p < 0.05,
Figure 5 Effect of GGDGT on expression of ICAM-1 in the aortas of WD-fed ApoE−/− mice. Western blots and corresponding densitometric
analysis of intercellular adhesion molecule (ICAM)-1 expression in aortic tissue. Data are expressed as a percentage of the density of blots and are
mean ± S.E. values (n = 3 mice per group). **p < 0.01 vs. regular diet (RD)-fed control mice; #p < 0.05, ##p < 0.01 vs. western diet (WD)-fed
ApoE−/− mice.
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mined by western blotting analysis. The WD-fed ApoE−/−
mice showed significantly increased aortic expression
levels of ICAM-1 compared with RD-fed control mice,
whereas treatment with GGDGT and rosiglitazone forFigure 6 Effect of GGDGT on the OGTT and expression of insulin rece
glucose (1.5 g/kg) was administered for an oral glucose tolerance test (OGT
insulin receptor substrate (IRS)-1 expression in the muscle tissue. Data are e
**p < 0.01 vs. regular diet (RD)-fed control mice; #p < 0.05, ##p < 0.01 vs. We12 weeks showed a lower band intensity of ICAM-1
compared with WD-fed ApoE−/− mice (60% decrease)
(Figure 5). Additionally, VCAM-1 and E-selectin immuno-
reactivity was increased in the aortas of WD-fed ApoE−/−
mice. However, VCAM-1 and E-selectin expression wasptors in the muscle tissue. (A) Mice were fasted overnight and
T). (B) Western blots and corresponding densitometric analysis of
xpressed as mean ± S.E. values (n = 3 mice per group). *p < 0.05,
stern diet (WD)-fed ApoE−/− mice.
Lee et al. BMC Complementary and Alternative Medicine 2014, 14:453 Page 9 of 11
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0.05 and 0.01, respectively) (Additional file 1: Figures S2
and S3). These finding suggest that GGDGT may have a
potentially important role in anti-inflammatory and anti-
atherosclerotic activity in diabetic vascular dysfunction.
Effects of GGDGT on glucose tolerance and insulin
receptor expression in skeletal muscle
Insulin resistance plays an important role in the develop-
ment of abnormalities such as impaired glucose tolerance,
type 2 diabetes, obesity, and hyperlipidemia [50]. In the
present study, an oral glucose tolerance test (OGTT)
was performed on WD-fed ApoE−/− mice. As shown in
Figure 6A, the mice were fasted overnight before glu-
cose was administered (1.5 g/kg). Over the entire time
course, blood glucose levels were higher in RD-fed control
mice than in WD-fed ApoE−/− mice; however, treatment
with GGDGT and rosiglitazone for 12 weeks further de-
crease blood glucose levels in ApoE−/− mice compared
with RD-fed control mice (p < 0.01 and p < 0.01, respect-
ively). Both the rise and fall of blood glucose levels were
slower in WD-fed ApoE−/− mice than in mice that were
treated with GGDGT. Insulin signalling from the insulin
receptor is transmitted through insulin receptor substrate
(IRS)-1. IRS-1 tyrosine phosphorylation has been impli-
cated in signal transduction from the insulin receptor to
phosphatidylinositol 3-kinase, leading to GLUT-4 trans-
location and subsequent glucose uptake [51-53]. To deter-
mine when and to what extent skeletal muscle tissues
become insulin insensitive, we investigated insulin signal-
ling, a key molecular event in the pathogenesis of fat-
induced insulin resistance in vivo. As shown in Figure 6B,
WD-fed ApoE−/− mice showed significantly decreased
IRS-1 expression compared with RD-fed control mice,
whereas mice receiving GGDGT and rosiglitazone recov-
ered normal expression of IRS-1. GGDGT improved glu-
cose tolerance, restored the expression of IRS-1 in skeletal
muscle, and decreased plasma insulin levels. These results
suggest that GGDGT ameliorates insulin resistance and
that its action is related to the insulin-signalling pathway
[54]. Furthermore, the results suggest that GGDGT ame-
liorated systemic vascular dysfunction, including vasocon-
striction and inflammation, through activation of insulin
signalling in WD-fed ApoE−/− mice.
Conclusions
Gal-geun-dang-gwi-tang has long been used for treatment
of vascular disorders, but the pharmacologic mechanisms
of the herbal combination are unknown. Treatment of
WD-fed ApoE−/− mice with GGDGT reduced hyperten-
sion by protecting the endothelium-dependent vasorelax-
ation response. GGDGT also improved total cholesterol
and triglyceride levels and reduced expression of the
vascular inflammation marker, ICAM-1. Furthermore,GGDGT ameliorated insulin resistance by decreasing
plasma levels of insulin, improving glucose tolerance,
and restoring insulin signalling by recovery of IRS-1
expression in skeletal muscle tissues. Accordingly, the
Korean medicine prescription GGDGT may be useful
in the treatment and prevention of diabetic vascular
complications. To our knowledge, this study is the first to
demonstrate the apparent anti-diabetic, anti-hypertensive,
hypolipidemic, and vascular anti-inflammatory effects of
GGDGT in an animal model of diabetic atherosclerosis.
Additional file
Additional file 1: Figure S1. Effect of GGDGT on high glucose (HG)-
induced ICAM-1, VCAM-1, and E-selectin expression in the HUVEC.
Figure S2. Effect of GGDGT on VCAM-1 expression in the aorta of
WD-fed ApoE-/- mice. Figure S3. Effect of GGDGT on E-selectin expression
in the aorta of WD-fed ApoE-/- mice.
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